Avricore Health CEO feels company is set up for success with new partnerships and emerging markets

About this update from Avricore Health Inc.

[{"type":"text","content":"Avricore Health CEO feels company is set up for success with new partnerships and emerging markets\n \n \n (NewsDirect)\n \n \n \n \n Avricore Health CEO Hector Bremner\ndiscussed the company's significant growth, partnerships, and\nexpansion into new markets during an interview with Steve Darling from\nProactive.\n \n \n Bremner shared how these\ndevelopments position Avricore Health for future success, with a\nstrong focus on the company's flagship product, HealthTab.\n \n \n Bremner emphasized that the core of\nAvricore Health's operations centers around HealthTab, an\ninnovative health monitoring solution. The company is working on\nexpanding the reach of HealthTab by partnering with more pharmacies\nnot only across Canada but also on a global scale.\n \n \n This expansion strategy aims to bring\nHealthTab's benefits to a wider audience and increase the\ncompany's market presence.\n \n \n Regarding financial performance, Bremner highlighted the\nimpressive growth achieved by Avricore Health. Revenues for the first\nhalf of 2023 reached $1,177,290, representing a remarkable 437%\nincrease compared to the same period in the previous year. This growth\nwas attributed to the deployment of more HealthTab systems and\nincreased tests sold.\n \n \n Additionally,\nthe company's gross profit surged by 511% to $440,152, with a\ngross margin of 37.39% — outperforming the company's target\nmargin of 30%. This performance underscores the solid fundamentals of\nthe company and its ability to increase scale while simultaneously\nimproving profitability.\n \n \n Avricore\nHealth's success story also includes its recent selection by a\ncollaborative effort involving the renowned Barts Heart Centre and the\nnational cardiovascular charity HEART UK.\n \n \n The company was chosen\nto assess the feasibility of integrating cholesterol testing into\ncommunity pharmacies in the UK. This initiative aims to complement\nopportunistic blood pressure checks, assess cardiovascular risk, and\nexpand clinical services offered to patients.\n \n \n \n Contact\nDetails\n \n \n \n Proactive Investors\n \n \n +1 604-688-8158\n \n \n \n [email protected]\n \n \n \n Copyright (c) 2023 TheNewswire - All rights reserved.\n \n \n","length":2774,"tagName":"div"}]

More updates from Avricore Health Inc.